跳转至内容
Merck
所有图片(1)

主要文件

查看所有文档

429066

Sigma-Aldrich

(3-溴丙氧基)-叔丁基二甲基硅烷

97%

别名:

(3-Bromopropoxy)(1,1-dimethylethyl)dimethylsilane, 1-((tert-Butyldimethylsilyl)oxy)-3-bromopropane, 1-Bromo-3-(tert-butyldimethylsiloxy)propane, 1-Bromo-3-[(tert-butyldimethylsilanyl)oxy]propane, 1-Bromo-3-[(tert-butyldimethylsilyl)oxy]propane, 3-((tert-Butyldimethylsilyl)oxy)-1-bromopropane

登录查看公司和协议定价
所有图片(1)

About This Item

线性分子式:
Br(CH2)3OSi(CH3)2C(CH3)3
CAS号:
89031-84-5
分子量:
253.25
MDL號碼:
MFCD00216589
分類程式碼代碼:
12352100
PubChem物質ID:
24866833
NACRES:
NA.22

品質等級

200

化驗

97%

形狀

liquid

包含

sodium carbonate as stabilizer

折射率

n20/D 1.451 (lit.)

bp

182 °C (lit.)

密度

1.093 g/mL at 25 °C (lit.)

官能基

bromo

儲存溫度

2-8°C

SMILES 字串

CC(C)(C)[Si](C)(C)OCCCBr

InChI

1S/C9H21BrOSi/c1-9(2,3)12(4,5)11-8-6-7-10/h6-8H2,1-5H3

InChI 密鑰

QGMROEZDWJTIDW-UHFFFAOYSA-N

相关类别

一般說明

(3-Bromopropoxy)-tert-butyldimethylsilane is a bromo silyl ether.

應用

(3-Bromopropoxy)-tert-butyldimethylsilane may be used to introduce propanol functionality to many pharmaceuticals.
It may be used as an alkylating agent in the synthesis of the following:
  • N-[2-[N-[3-(tert-butyldimethylsilyloxy)propyl]-N-ethylamino]ethyl]phthalimide
  • O-(3-tert-butyldimethylsilyloxypropyl)-N-(tert-butoxycarbonyl)-L-tyrosine methyl ester
  • tert-butyldimethyl-[3-(3-methyl-2-nitrophenoxy)propoxy]silane

象形圖

Exclamation mark
GHS07

訊號詞

Warning

危險聲明

H315,H319,H335

危險分類

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

標靶器官

Respiratory system

儲存類別代碼

10 - Combustible liquids

水污染物質分類（WGK）

WGK 3

閃點（°F）

185.0 °F - closed cup

閃點（°C）

85 °C - closed cup

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
MKCG8363
MKCC1464
MKBV1494V
MKBG6678
MKBF5077

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Synthesis of O-(3-[18F] Fluoropropyl)-L-tyrosine (L-[18F] FPT) and its biological evaluation in 9L tumor bearing rat.
Moon BS, et al.
Bull. Korean Chem. Soc., 26(1), 91-96 (2005)
Ramani R Ranatunge et al.
Journal of medicinal chemistry, 47(9), 2180-2193 (2004-04-16)
The synthesis of a series of novel pyrazoles containing a nitrate (ONO(2)) moiety as a nitric oxide (NO)-donor functionality is reported. Their COX-1 and COX-2 inhibitory activities in human whole blood are profiled. Our data demonstrate that pyrazole ring substituents
A concise total synthesis of (+/-)-vigulariol.
J Stephen Clark et al.
Angewandte Chemie (International ed. in English), 46(3), 437-440 (2006-12-06)
Han-Cheng Zhang et al.
Bioorganic & medicinal chemistry letters, 14(12), 3245-3250 (2004-05-20)
A novel series of acyclic 3-(7-azaindolyl)-4-(aryl/heteroaryl)maleimides was synthesized and evaluated for activity against GSK-3beta and selectivity versus PKC-betaII, as well as a broad panel of protein kinases. Compounds 14 and 17c potently inhibited GSK-3beta (IC(50)=7 and 26 nM, respectively) and
Synthesis, radioiodination and in vivo screening of novel potent iodinated and fluorinated radiotracers as melanoma imaging and therapeutic probes.
Maisonial A, et al.
European Journal of Organic Chemistry, 63, 840-853 (2013)
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门